2018 financial statements
Conference call on March 20, 2019 Management Participants: Mondher Mahjoubi, CEO, Laure-Helene Mercier, CFO, Pierre Dodion, CMO, and Jennifer Butler, US General Manager
Welcome to Innate Pharma
Scroll
About Innate Pharma
Innate Pharma S.A. is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Headlines
ASH 2018: updated results on IPH4102 and KOL webcast
A KOL webcast and conference call was held on Tuesday, December 4, at 5pm CET (8am PST)
Innate Pharma strengthens and expands its oncology development collaboration with AstraZeneca
Conference call for analysts and investors to discuss this announcement.
Latest news
Innate Pharma First Quarter 2019 Report
May 15, 2019
Upcoming events
ASCO Annual Meeting | Chicago, USA
May 31, 2019 to June 4, 2019
ESMO Congress 2019 | Barcelona, Spain
September 27, 2019 to October 1, 2019
SITC 2019 | National Harbor, USA
November 6, 2019 to November 10, 2019